Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome.
Mol Med
; 27(1): 48, 2021 05 11.
Article
in En
| MEDLINE
| ID: mdl-33975537
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers
/
HMGB1 Protein
/
Etoposide
/
Macrophage Activation Syndrome
Type of study:
Etiology_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
En
Journal:
Mol Med
Journal subject:
BIOLOGIA MOLECULAR
Year:
2021
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United kingdom